Johnson & Johnson offers up to $5.5bn to settle US baby powder lawsuits

Pharmaceutical giant Johnson & Johnson has proposed a settlement of up to $5.5 billion to resolve thousands of long-standing lawsuits alleging that its talc-based baby powder products are linked to cancer. The offer marks a significant development in a years-long legal battle that has seen the company face intense scrutiny over the safety of its consumer products.

For years, plaintiffs have claimed that the company's talc products were contaminated with asbestos, leading to cases of ovarian cancer and mesothelioma. Johnson & Johnson has consistently maintained that its talc products are safe and do not contain asbestos, characterizing the litigation as meritless while simultaneously seeking a legal path to resolve the mounting financial and reputational pressure.

The proposed settlement is intended to provide a comprehensive resolution to the claims, which have been consolidated in various courts across the United States. If finalized, the deal would represent one of the largest product liability settlements in the company's history, aimed at closing a chapter of litigation that has persisted for over a decade.

Legal experts suggest that the move is a strategic effort by the company to mitigate further uncertainty and legal costs. While the settlement offer is a major step toward resolution, it remains subject to approval by the relevant courts and the participation of the plaintiffs involved. Johnson & Johnson continues to face ongoing challenges as it navigates the complex regulatory and public perception landscape surrounding its legacy talc business.